The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families

Rogier Oldenburg; K Kroeze-Jansema; J Kraan; H Morreau; Jan Klijn; N Hoogerbrugge; MJL Ligtenberg; CJ van Asperen; HFA Vasen; C Meijers; EJ Meijers-Heijboer; TH de Bock; CJ Cornelisse; P Devilee

The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families

Rogier Oldenburg, K Kroeze-Jansema, J Kraan, H Morreau, Jan Klijn, N Hoogerbrugge, MJL Ligtenberg, CJ van Asperen, HFA Vasen, C Meijers, EJ Meijers-Heijboer, TH de Bock, CJ Cornelisse, P Devilee

Research output: Contribution to journal › Article › Academic › peer-review

109 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	8153-8157
Number of pages	5
Journal	Cancer Research
Volume	63
Publication status	Published - 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{3ab953dcc17a4fabb9d9c55c1685d275,

title = "The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families",

author = "Rogier Oldenburg and K Kroeze-Jansema and J Kraan and H Morreau and Jan Klijn and N Hoogerbrugge and MJL Ligtenberg and {van Asperen}, CJ and HFA Vasen and C Meijers and EJ Meijers-Heijboer and {de Bock}, TH and CJ Cornelisse and P Devilee",

year = "2003",

language = "Undefined/Unknown",

volume = "63",

pages = "8153--8157",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families

AU - Oldenburg, Rogier

AU - Kroeze-Jansema, K

AU - Kraan, J

AU - Morreau, H

AU - Klijn, Jan

AU - Hoogerbrugge, N

AU - Ligtenberg, MJL

AU - van Asperen, CJ

AU - Vasen, HFA

AU - Meijers, C

AU - Meijers-Heijboer, EJ

AU - de Bock, TH

AU - Cornelisse, CJ

AU - Devilee, P

PY - 2003

Y1 - 2003

M3 - Article

VL - 63

SP - 8153

EP - 8157

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

ER -